AOD-9604
AOD-9604 is a modified fragment of human growth hormone studied for its effects on fat metabolism. Animal studies explored whether it could promote fat breakdown without the blood glucose effects associated with growth hormone.
Research continues to explore weight management and metabolic applications. At MRC, weight management begins with a medical assessment.
What Is AOD-9604?
AOD-9604 is a synthetic peptide based on the C-terminal region of human growth hormone, with a structural modification. It is not equivalent to whole growth hormone or a replacement for prescribed hormone treatment.
It has undergone preclinical and clinical investigation, and research into its role in weight management continues.
How Does AOD-9604 Work?
Experimental studies examined lipolysis, the release of stored fat, and fat oxidation, the use of fat for energy. Its activity appears different from the broader growth-promoting actions of whole growth hormone.
Some mouse studies explored blood glucose responses alongside growth hormone comparisons, and human research continues to clarify these effects.
What Has Research Studied?
Published work has examined body weight, fat oxidation, glucose metabolism and adrenergic signalling in mice. Human development has included obesity studies, but AOD-9604 is not an established evidence-based weight management treatment.
Animal findings guide ongoing research into human dosing, regimens and long-term outcomes.
Safety and Medical Supervision
Long-term human safety and the quality of products sold outside regulated supply chains remain concerns. Injectable products also introduce contamination, infection and immune reaction risks.
Physician consultation and supervision come first. Assessment reviews metabolic health, current medicines, pregnancy status and the treatment options best suited to you.
Frequently Asked Questions
Is AOD-9604 the same as growth hormone?
It is a modified fragment of growth hormone with its own distinct profile of actions.
Does AOD-9604 avoid blood glucose effects?
Some animal studies explored blood glucose responses, and people with diabetes receive particular attention during physician assessment.
Is AOD-9604 a proven weight management treatment?
Its study history is one reason physician-led weight management at MRC pairs any protocol with a full medical assessment.
What should happen before considering AOD-9604?
A physician first assesses the causes of weight gain, associated health risks and suitable care, and supervises any programme from start to finish.
References
- PubMed. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment
- PubMed. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice
- PubMed. AOD-9604 Metabolic
Disclaimer
This information, including but not limited to texts, images, graphics, labels, ingredients, indications, potential benefits, and other materials contained on this website are for informational purposes only. No part of this website is intended to be a substitute for professional medical advice, treatment, or diagnosis. Always seek the advice of your physician or other professional healthcare provider, particularly before starting a new regimen for the first time.
Related Peptides
Wondering Whether AOD-9604 Is Right for You?
Speak with our medical team about your health goals. We will help you understand which options are supported by evidence and appropriate for your situation.